4(1H)-pyrimidinones
US4034093A · kind A · utility
9Cited by
1References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 4, 1973 |
| Grant date | Jul 5, 1977 |
| Priority date | — |
| Expiry date | Sep 4, 1993 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C251/72
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Therapeutically-active and pharmacologically-acceptable 1-amido-5-cyano-4(1H)-pyrimidinones and their pharmaceutically-acceptable acid addition salts inhibit xanthineoxidase and are useful as the active ingredient in medicaments for the treatment of gout. Such pyrimidinones are prepared by treating 2-(acyl) hydrazonomethyl-3-chloro or hydroxy-4-aza-2,4-pentadienenitriles with acid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.